Mylan's Robert Coury - CEO Pay
Robert Coury - Mylan 
Total Compensation: $8.54M
2007 Revenue: $2.17B
2006 Revenue: $1.61B
Change: 34%
Details: Mylan CEO and Vice Chairman Robert Coury brought down $10.3 million during fiscal 2007, which ran only nine months because the drugmaker changed its fiscal year. Coury earned salary of about $1.12 million, stock awards of $1.15 million, and about $2.1 million in incentive compensation. Mylan was the only company that primarily produces generics drugs to grace our top 17.
Mylan News:
Mylan CEO intent on new global biz
Mylan CEO makes $10M in 9 months
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets